Lionbridge Technologies, Inc., the translation and digital communications company, announced updates to its Clinical Labeling translation solution, an end-to-end offering that helps global life sciences organizations translate labeling content for clinical studies while remaining compliant with global regulatory requirements.
The features of the Clinical Labeling solution include an updated, fully customizable workflow for label text creation, translation and validation across more than 100 markets and languages. In addition, Lionbridge Life Sciences has integrated its labeling translation solution with suppliers of clinical labeling design, production, and management services, allowing integration of translation processes within clients' existing labeling management platforms.
"As a global leader in clinical supply chain solutions, we needed a partner that could deliver accurate clinical labels while integrating regulatory compliance, packaging capabilities and country validation," said Jamie Pieron, Manager of Client Services Operations, Clintrak Clinical Labeling Services. "By leveraging Lionbridge's expansive global regulatory network and expertise, we can continue to provide our clients with a clinical labeling model that improves efficiency and reduces overall risk."
Lionbridge's technology platform, combined with Lionbridge's network of qualified translators and regulatory experts enables pharmaceutical and biotechnology organizations to reduce the overall label cycle times and simplify global label creation. Key benefits of the updated Lionbridge Clinical Labeling solution include:
To learn more, visit http://lifesciences.lionbridge.com/what-we-do/services-function/regulatory/.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.